Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2012 Aug 6;287(40):33905–33916. doi: 10.1074/jbc.M112.401646

On the Roles and Regulation of Chondroitin Sulfate and Heparan Sulfate in Zebrafish Pharyngeal Cartilage Morphogenesis*

Katarina Holmborn ‡,1, Judith Habicher §,1, Zsolt Kasza , Anna S Eriksson , Beata Filipek-Gorniok , Sandeep Gopal ¶,2, John R Couchman ¶,2, Per E Ahlberg , Malgorzata Wiweger ‖,3, Dorothe Spillmann , Johan Kreuger ‡,4,5, Johan Ledin §,4,6
PMCID: PMC3460485  PMID: 22869369

Background: Chondroitin sulfate (CS) and heparan sulfate (HS) are important for cartilage formation.

Results: Analyses of zebrafish mutants demonstrate interplay between HS and CS biosynthesis in vivo.

Conclusion: HS biosynthesis is prioritized over CS biosynthesis. The balance between extl3 and csgalnact1/csgalnact2 function determines the HS/CS ratio.

Significance: Disease progression caused by HS deficiency may be affected by altered CS biosynthesis.

Keywords: Biosynthesis, Cartilage, Chondroitin Sulfate, Heparan Sulfate, Morphogenesis, b3gat3, ext2, extl3, uxs1

Abstract

The present study addresses the roles of heparan sulfate (HS) proteoglycans and chondroitin sulfate (CS) proteoglycans in the development of zebrafish pharyngeal cartilage structures. uxs1 and b3gat3 mutants, predicted to have impaired biosynthesis of both HS and CS because of defective formation of the common proteoglycan linkage tetrasaccharide were analyzed along with ext2 and extl3 mutants, predicted to have defective HS polymerization. Notably, the effects on HS and CS biosynthesis in the respective mutant strains were shown to differ from what had been hypothesized. In uxs1 and b3gat3 mutant larvae, biosynthesis of CS was shown to be virtually abolished, whereas these mutants still were capable of synthesizing 50% of the HS produced in control larvae. extl3 and ext2 mutants on the other hand were shown to synthesize reduced amounts of hypersulfated HS. Further, extl3 mutants produced higher levels of CS than control larvae, whereas morpholino-mediated suppression of csgalnact1/csgalnact2 resulted in increased HS biosynthesis. Thus, the balance of the Extl3 and Csgalnact1/Csgalnact2 proteins influences the HS/CS ratio. A characterization of the pharyngeal cartilage element morphologies in the single mutant strains, as well as in ext2;uxs1 double mutants, was conducted. A correlation between HS and CS production and phenotypes was found, such that impaired HS biosynthesis was shown to affect chondrocyte intercalation, whereas impaired CS biosynthesis inhibited formation of the extracellular matrix surrounding chondrocytes.

Introduction

The pharyngeal apparatus is a vertebrate-specific structure that arises from all three germ layers. In zebrafish, the pharyngeal apparatus gives rise to the pharyngeal cartilage. One of the main functions of this cartilage is to provide mechanical support to the skeletal structures of the head and jaw. Pharyngeal cartilage formation begins as neural crest-derived prechondrocytic cells differentiate to chondrocytes and begin to secrete an extracellular matrix (ECM)7 rich in collagen and proteoglycans (PGs) (1, 2). The early cartilage elements are then shaped in a process where the chondrocytes intercalate and flatten. This generates long and slender early cartilages elements that generally are one cell thick, somewhat similar to a stack of coins (3). The ability to make rod-like cartilages by intercalation of chondrocytes is conceivably ancient in vertebrates. These structures are present in both lamprey (4) and osteichthyans, showing that it is an ancestral vertebrate trait with a history probably extending back more than 500 million years. Direct evidence for its early existence comes from the 380-million-year-old fossil Euphanerops, a jawless vertebrate possibly related to lamprey (5). Mineralized fragments of gill arch cartilages from this animal clearly show a cellular organization indistinguishable from that in modern examples, such as the zebrafish (supplemental Fig. S1). The mechanisms producing the characteristic cellular architecture of cartilages are thus likely to be both very old and of great importance for vertebrate morphogenesis in general.

An ECM, important for chondrogenesis and cartilage morphogenesis, is deposited between chondrocytes and the overlaying perichondrium (2). This ECM is rich in PGs carrying covalently attached glycosaminoglycan (GAG) polysaccharide side chains of heparan sulfate (HS) or chondroitin sulfate (CS) type. HS and CS differ with regard to the composition of the polysaccharide backbones, but HS and CS are similar in that they both have a high content of O-sulfate groups. These sulfate groups form clusters of negative charge along the GAG chains that mediate interactions with positively charged surfaces on protein ligands (6). Examples of signaling proteins relevant to cartilage and bone formation that interact with PGs include bone morphogenetic proteins, hedgehogs, Wnt signaling proteins, and fibroblast growth factors (7). PGs are abundantly expressed at the cell surface of most types of cells, including chondrocytes, and function as co-receptors. Others and we have shown that PGs shape the gradients of secreted morphogens during development to impact organ formation (8).

A number of genes involved in PG biosynthesis have been shown to be crucial for the development of the jaw and the pharyngeal arches in zebrafish, including glypican 4 (gpc4/knypek) (9, 10), UDP-glucuronic acid decarboxylase 1 (uxs1) (11, 12), exostosin 2 (ext2/dackel) (1215), exostoses (multiple)-like 3 (extl3/boxer) (15), udp-glucose dehydrogenase (ugdh/jekyll) (16, 17), and solute carrier family 35, member B2 (slc35b2/pincher, reported as papst1) (13). From previous studies of these genes, it stands relatively clear that PGs are required for the intercalation of chondrocytes during the formation of rod-like cartilage structures. For example, in ext2 mutants suggested to synthesize only a fraction of normal HS levels (14), chondrocytes were found to be incapable of forming columns (13, 15). Interestingly, the uxs1 gene has been suggested to be crucial for both HS and CS synthesis and shown by Eames et al. (11) to develop a cartilage phenotype similar to that found in ext2 mutants, which would suggest that removal of CS in addition to the lack of HS would not result in a strengthened phenotype. From this it may be concluded that low HS content is the main reason for the abnormal cartilage development in both ext2 and uxs1 mutants. However, although ext2 mutants also exhibit an almost complete absence of pectoral fin development, uxs1 mutants were shown to develop only a mild pectoral fin phenotype (11, 14, 18). Because pectoral fin development is demonstrated to be dependent on HS (19), this would suggest that the block of HS biosynthesis is incomplete in uxs1 mutants.

Here we present a systematic investigation to show both qualitatively and quantitatively how the biosynthesis of HS and CS is affected in ext2, extl3, uxs1, and glucuronosyltransferase 1 (b3gat3) mutants. Of note, these transgenic lines are effectively partial loss of function mutants for HS and CS biosynthesis, because of enzyme redundancy and maternal contribution. Our analyses show that the relatively mild cartilage phenotype seen in extl3 mutants can be explained by increased production of CS. It was hypothesized that there is an interplay between HS and CS biosynthesis, and this was confirmed using experiments with morpholinos targeting chondroitin sulfate synthase 1 (chsy1) or the two chondroitin sulfate N-acetyl-galactosaminyltransferase (csgalnact) 1 and 2. Further, analyses of uxs1 and b3gat3 mutants show that HS biosynthesis is prioritized over CS biosynthesis in a situation where the levels of PG linkage tetrasaccharides are reduced. Finally, ext2;uxs1 double mutants with severely reduced capacity to produce both HS and CS were shown to develop a stronger cartilage phenotype when compared with the individual mutants.

EXPERIMENTAL PROCEDURES

Fish Stocks

Zebrafish embryos were obtained in natural crosses. The following mutant lines were used: ext2tw25e and extl3Tm70G (14) and b3gat3hi307 and uxs1hi954 (20). In addition, the wild-type lines Wik and Tubingen were used, as well as the transgenic line Tg(fli1:EGFP)y1 (21). To be able to follow cartilage development by live imaging, all mutant lines were crossed with Tg(fli1:EGFP)y1. To obtain double mutants, the ext2tw25e allele was crossed into uxs1hi954; Tg(fli1:EGFP)y1 background, and homozygous double mutants were sorted by phenotype. Embryos were cultured in system water, with or without the addition of 0.003% 1-phenyl-2-thiourea (Sigma) to inhibit pigmentation and staged using hours post fertilization (hpf) (22). Homozygous mutants were identified based on phenotype. Prior to freezing or fixing, embryos were anesthetized in tricaine methanesulfonate (Sigma-Aldrich).

Confocal Imaging of Zebrafish

Cartilage and bone development was followed in zebrafish embryos and larvae using a Zeiss confocal laser scanning microscope 700 with an additional heating and CO2 chamber. The fish were anesthetized and embedded in 1% soft agarose containing 1% tricaine and kept at 28 °C during all experiments. For visualization of bone development, the larvae were incubated in 0.3% alizarin red (Sigma-Aldrich) in system water for 12 h prior to live imaging. For time lapse analysis, the fish were followed for 50 h beginning at 55 hpf; z-stacks were captured every 20 min.

Genotyping

DNA extraction of larvae was carried out by incubating the larvae in 100 μl of 10 mm Tris, pH 8, 2 mm EDTA, and 0.2% Triton X-100 at 55 °C for 2 h, followed by 3 min at 96 °C. The PCR was initiated with a denaturation step at 94 °C for 3 min followed by amplification for 30 cycles (94 °C for 30 s, 50 °C for 40 s, and 72 °C for 45s) and an elongation step at 72 °C for 5 min. In each genotyping PCR, three primers were added for either b3gat3 or uxs1, two flanking the retroviral insert and one within the insert. This resulted in a 165-bp fragment for the b3gat3 mutant allele and 360 bp for the wild-type allele or a 175-bp fragment for the uxs1 mutant allele and a 375-bp fragment for the wild-type allele. The primers used are: b3gat3 forward, 5′-GCCGAGACTGAAGGAGACCCT-3′, and reverse, 5′-GCGGAAGTTGCTGGTAGTCCG-3′; uxs1 forward, 5′-ACACACGGCATCGAACTCTTCTTTA-3′, and reverse, 5′-GCTGCAAGTCTAGAGTCATGTCG-3′; and primer in the retroviral insert 5′-GCTAGCTTGCCAAACCTACAGGT-3′.8 PCR products were analyzed on a 1% agarose-gel. ext2 mutants were identified based on their complete lack of pectoral fins (23).

Transmission Electron Microscopy

Zebrafish larvae were fixed in a mixture of 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 m PBS at 4 °C overnight, followed by three washing steps with PBS, for 10 min each. The larvae were postfixed in 1% OsO4 for 30 min and washed three times with PBS for 15 min each. Dehydration was performed in a series of 20, 30, 50, 70, 80, 90, 96, and 100% (2×) ethanol and 100% (2×) aceton. The samples were infiltrated 1:1 aceton:resin overnight and then transferred to 100% resin and incubated overnight. The larvae were embedded in fresh resin and polymerized at 50 °C for 2 days. Thin sections were contrasted with uranyl acetate and lead citrate. Grids were observed in a Zeiss supra 35-VP field emission SEM, equipped with a scanning transmission electron microscope detector for transmission microscopy at an accelerating voltage 25 kV.

Structural Analysis of HS and CS by Reverse Phase Ion Pair (RPIP)-HPLC

HS and CS were isolated from zebrafish embryos and larvae, degraded into disaccharides by enzymatic cleavage, and detected in a HPLC-based system essentially following the protocol described earlier (24). In short, GAGs were isolated by proteolytic cleavage, nuclease treatment, and DEAE ion exchange chromatography. The purified GAGs were cleaved with chondroitinase ABC, and 10% of the sample was analyzed to identify CS disaccharide components. HS was purified from the GAG fraction by a second DEAE purification step followed by cleavage with heparin lyases I–III. The two generated samples of HS and CS disaccharides, respectively, were subjected to RPIP-HPLC analysis followed by post-column derivatization with cyanoacetamide and detection in a fluorescence detector, essentially as described (24). The identity and the amount of the disaccharides were established by comparing the samples with HS and CS disaccharide standards. At least four samples were run for each mutant/morphant with siblings from the same clutch as matching controls, with the exception of ext2;uxs1 mutants, which were run in duplicate.

Alcian Blue Staining

Alcian blue staining was performed on 4- and 6-dpf larvae as described previously (17).

Morpholino Injections

Morpholino (MO) antisense oligomers MO1-chsy1 and MO3-chsy1 (25) were used. The embryos were injected at the one-cell stage with a combination of 0.25 pmol of MO1-chsy1 and 1.28 pmol of MO3-chsy3 and at 24 hpf collected for RPIP-HPLC analysis of HS and CS. The zebrafish csgalnact1 (accession number XM_001333443) and csgalnact2 (accession number NM_001126397) orthologs were identified by using human sequences for CSGALNACT1 (reference number AB071403) and CSGALNACT2 (reference number BC030268) for a comparative TBLASTN analysis against the zebrafish genome database. Morpholinos for zebrafish csgalnact1 (5′-CACAACTGGCAACCTCAACAACAAG-3′) and csgalnact2 (5′-GATCTTCACCAGCCACAGTTTTGCA-3′) MOs were designed against the respective translational start sites to knock down maternal and zygotic expression. The embryos were injected at the one-cell stage with a combination of 0.27 pmol of MO-csgalnact1 and 0.27 pmol of MO-csgalnact2 and at 30 hpf were collected for RPIP-HPLC analysis of HS and CS. All morpholinos were purchased from GeneTools (Philomath, OR). Injections were done using a Narishige IM-31 microinjector (Narishige, Tokyo, Japan).

Real Time Quantitative PCR Analysis of Differential Gene Expression

RNA was isolated from pools of ∼20 zebrafish embryos at 6 dpf using the miRNeasy mini kit (Qiagen). cDNA was synthesized using the iScript cDNA synthesis kit (Bio-Rad). Quantitative RT-PCRs were carried out using the SsoFast EvaGreen supermix (Bio-Rad). Amplification efficiency was determined using dilution series of the templates. Primer specificity was confirmed by melt-curve analysis and agarose gel analysis. All primer pairs used are shown in supplemental Table S1. Calculation of relative gene expression was performed using the 2 − ΔΔCT method (reference gene rpl13a) and normalization of the data to average gene expression levels in wild-type embryos. The p values for differential gene expression in extl3 mutants versus wild type were calculated using the unpaired two-tailed Student's t test.

Size Analysis of GAGs Isolated from Zebrafish Embryos

Embryos were injected in the yolk with radioactive sulfate (35S) at 5 dpf and harvested after 18 h, after which GAGs were isolated by protease and benzonase digestions, followed by DEAE (GE Healthcare) anion exchange chromatography, essentially as described previously (24). Purified GAGs were alkaline treated at a final concentration of 0.5 m NaOH for 16 h at 4 °C, and an aliquot of the reaction mixture was analyzed on Superose 6 (GE Healthcare Biosciences). The rest of the sample was subjected to either CSase ABC treatment (50 milliunits/sample), nitrous acid treatment at pH 1.5, or a combination of both these treatments prior to size analysis on a Superose 6 column followed by 35S analysis by liquid scintillation counting.

Structural Analysis of GAG Chains Attached to AAS Syndecan-4

Transfections of HEK293 cells with an expression construct for HA-tagged AAS syndecan-4 (26) having only a single GAG attachment site, with or without co-transfection with EXTL3 siRNA (Invitrogen; identification number 116968) were carried out using Ingenio transfection solution (Mirus Bio LLC) on a nucleofector device (Amaxa Inc.). 24 h post-transfection, the cells were labeled with 50 μCi/ml [3H]glucosamine (PerkinElmer Life Sciences; specific activity, 37 Ci/mmol) for 24 h and harvested, and cell lysis was performed. HA-tagged AAS syndecan-4 was isolated using immunoprecipitation using a specific anti-HA antibody (H9658; Sigma) coupled to Dynabeads Protein G (Invitrogen), according to the manufacturer's instructions. The GAG chains were isolated as described above, and part of the samples were digested with either CSase ABC (50 milliunits/sample), nitrous acid treatment at pH 1.5, or a combination of both treatments prior to size separation on a Superose 12 column (GE Healthcare) followed by 3H analysis by liquid scintillation counting.

RESULTS

Analysis of Zebrafish Cartilage Development by Live Imaging of EGFP-expressing Chondrocytes

To study the roles of HS and CS in pharyngeal development, we performed a systematic comparison of pharyngeal defects in fish having mutations in enzymes of the GAG biosynthetic pathway. ext2 and extl3 mutants, defective in enzymes directly involved in HS polymerization, were analyzed together with uxs1 and b3gat3 mutants, predicted to have defective formation of the PG tetrasaccharide linkage region, presumably with consequences for both HS and CS biosynthesis (Fig. 1) (11, 14, 20). All of the investigated enzymes are ubiquitously expressed during zebrafish development (11, 14) (supplemental Fig. S2). We initially crossed all mutant alleles into the fli:EGFP genetic background to enable time lapse imaging using confocal microscopy of developing cartilages, because chondrocytes in this transgenic line have been shown to express GFP (21).

FIGURE 1.

FIGURE 1.

Biosynthesis of GAGs. The biosynthesis of HS and CS is initiated by the formation of a common PG tetrasaccharide linkage region. The first hexosamine added commits the intermediate to either HS or CS. The cartoon depicts key enzymatic reactions in the biosynthesis of HS and CS analyzed in the present study. Acronyms for genes whose functions are studied in zebrafish mutants are shown in colored boxes, and acronyms for genes whose functions are investigated by morpholino injections are shown in framed boxes.

The organization of chondrocytes into cartilage elements normally begins at ∼50 hpf. We initially followed the development of the pharyngeal cartilage in fli:EGFP transgenic embryos (here referred to as control) between 55 and 102 hpf by confocal microscopy. Chondrocytes in the pharyngeal cartilage elements were shown to adopt an elongated shape and to orient themselves perpendicular to the longitudinal axis of respective cartilage elements at ∼60 hpf. Subsequently, intercalation occurred to produce elements where most cartilage cells span from one side of the perichondrium to the other (Fig. 2, A and F, and supplemental Movie S1) (3).

FIGURE 2.

FIGURE 2.

extl3 mutants have a milder cartilage phenotype compared with ext2, uxs1, and b3gat3 mutants. Ventral views of pharyngeal cartilage elements of fli1:EGFP zebrafish larvae at 4 and 6 dpf. In wild-type larvae (A, F, and K), chondrocytes intercalate and elongate to form ordered parallel stacks resulting in slender cartilage structures. In contrast, fish homozygous for mutations in the GAG biosynthetic enzymes extl3 (B, G, and L), ext2 (C, H, and M), uxs1 (D, I, and N), and b3gat3 (E, J, and O) all exhibit abnormal cartilage formation. ext2, uxs1, and b3gat3 mutants display the strongest phenotypes with abnormally short and disorganized cartilage structures, where mutant chondrocytes generally appear round and do not display complete intercalation. The exl3 mutant cartilage phenotype is markedly milder. The rectangles in K–O indicate magnified areas shown in A–J. The areas where bone is forming are stained with alizarin red. P–T show schematic drawings of cartilage structures in the first five pharyngeal arches. bh, basihyal; ch, ceratohyal; hs, hyosymplectic; m, Meckel's cartilage; pq, palatoquadrate.

Chondrocytes in ext2 Mutants Remain Immobile during Initial Cartilage Organization

In ext2 mutants, the chondrocytes have previously been shown to be incapable of proper intercalation (13, 15). Time lapse analysis of ext2 mutants revealed that the formation of the Meckel's cartilage appeared normal until 65 hpf. Thereafter, chondrocytes in ext2 mutants gradually stopped moving to finally become immobile (supplemental Movie S2). Notably, other complex morphogenetic processes in ext2 mutants, such as the formation of the heart and blood vessels, apparently proceeded in a normal fashion during the same time period (supplemental Movies S1 and S2). These results underline that chondrocyte organization and cartilage morphogenesis is particularly sensitive to a reduction of ext2 function.

uxs1 and b3gat3 Mutants Exhibit Abnormal Pharyngeal Cartilage Morphogenesis

The pharyngeal cartilage elements of ext2, uxs1, and b3gat3 mutants were shown to be shorter and thicker than those of control larvae (Fig. 2). Rearrangement and proper intercalation of chondrocytes rarely occurred in these mutants, resulting in short and thick cartilage elements. The defects in chondrocyte intercalation affected the overall development of the jaw region, which was compressed along the anterior-posterior axis to a similar extent in ext2, uxs1, and b3gat3 mutants (Fig. 2, P and R–T).

Chondrocytes Intercalate in extl3 Mutants

To better understand the effects of defective HS and CS biosynthesis in pharyngeal cartilage development, we extended our analysis to include extl3 mutants (Fig. 1). extl3 mutants have previously been shown to synthesize slightly more HS than ext2 mutants (14), whereas the extl3 mutant pectoral fin phenotype is similar (Fig. 2L) compared with uxs1 and b3gat3 mutants (Fig. 2, N and O). However, in comparison with ext2, uxs1, and b3gat3 mutants, extl3 mutants develop significantly milder pharyngeal cartilage phenotypes. Accordingly, many chondrocytes in the Meckel's cartilage and the ceratohyal cartilage were shown to be flattened and oriented perpendicular to the length of the arch elements (Fig. 2, B and G) (15). extl3 mutants are thus in part able to organize chondrocytes similar to wild type (Fig. 2, A and F), although the organization of chondrocytes into single-cell rods often is incomplete (Fig. 2G). The milder cartilage phenotype in extl3 mutants was also manifested by a significantly more efficient extension of the pharyngeal cartilages along the anterior-posterior axis (Fig. 2Q) compared with the other mutant strains (Fig. 2, R–T), but the extl3 mutants still exhibited slightly shorter and thicker cartilages as compared with control larvae (Fig. 2P). The extl3 mutant pharyngeal cartilage phenotype is thus a mild version of the phenotypes observed in ext2, uxs1, and b3gat3 mutants, whereas paradoxically the pectoral fin phenotype is similar in extl3, uxs1, and b3gat3 mutants (Fig. 2, K–O). It could be assumed that mutations in ext2 and extl3 would result in defective HS biosynthesis but have no effect on CS biosynthesis. Mutations in uxs1 and b3gat3 mutants would, on the other hand, be expected to have defective or even absent biosynthesis of both HS and CS (Fig. 1). The comparison of the pharyngeal cartilage and the pectoral fin phenotypes in extl3, ext2, uxs1, and b3gat3 mutants, however, suggested that this assumption is an oversimplification and that mutations in these enzymes may have other effects on HS and CS biosynthesis than predicted based on their respective positions in the GAG biosynthetic pathway.

HS Content Correlates to the Pectoral Fin Phenotype

To be able to correlate the observed morphological phenotypes with the actual effects on GAG biosynthesis, we performed a detailed quantitative comparison of HS and CS biosynthesis in all the mutants. Offspring from crossings of heterozygous mutant strains were based on gross mutant morphology sorted into two pools: mutant larvae and unaffected siblings (control). Total GAGs from wild-type fish as well as from the above described crosses of the mutant lines were isolated at 6 dpf and analyzed by RPIP-HPLC analysis (see “Experimental Procedures”). This method has the advantage of allowing the determination of both the total HS and CS content, as well as the relative occurrence of the different modified (sulfated) disaccharide species present in respective GAG pools (24). We found that extl3 mutants have a higher HS content (44% of control) than ext2 mutants (17% of control) at 6 dpf, in line with previously reported results (14). Surprisingly however, uxs1 and b3gat3 mutants were shown to contain half of the normal HS content (52 and 55% of control, respectively) (Fig. 3A). Thus, the severity of the pectoral fin phenotype, but not the pharyngeal cartilage phenotype, was shown to correlate to the HS content in the different mutant larvae.

FIGURE 3.

FIGURE 3.

In addition to reduced HS biosynthesis, uxs1 and b3gat3 mutant larvae exhibit severely reduced CS biosynthesis, whereas extl3 mutants have increased CS production. HS and CS were quantitatively isolated from the various zebrafish strains at 6 dpf and analyzed using RPIP-HPLC, as described previously (24). A, the amounts of HS and CS (pmol/larvae) in the mutant lines are shown as percentages of the levels found in sibling controls (set to 100%). Whereas all enzyme mutants show a reduced production of HS (17–55% of wild type), the different mutant strains differ greatly in their production of CS. B and C, the amounts of HS and CS (pmol/larvae) in zebrafish larvae at 6 dpf injected with morpholinos targeting chsy1 (B) or csgalnact1 and csgalnact2 mRNA (C), here shown as percentages of the levels found in sibling controls (set to 100%). Whereas suppression of chsy1 only reduces CS production, suppression of csgalnact1 and csgalnact2 results in reduced CS production together with increased HS production. The asterisks illustrate a significant difference in disaccharide content as compared with sibling controls (p < 0.05).

The Level of CS Biosynthesis Correlates to the Cartilage Phenotypes

Analysis of the CS content at 6 dpf made it possible to address the hypothesis that the combined amounts of HS and CS might correlate to the pharyngeal cartilage mutant phenotypes. Surprisingly, uxs1 and b3gat3 mutants were shown to have very low levels of CS (5 and 11%, respectively, of control). Thus, the inability to efficiently form the PG tetrasaccharide linkage region in these mutants resulted in a much more dramatic reduction of CS biosynthesis as compared with HS biosynthesis (Fig. 3A). CS biosynthesis in ext2 mutants was, in contrast, similar to the wild type (88% of control). Interestingly, extl3 mutants were shown to produce more CS than control larvae (147% of control) (Fig. 3A), indicating that reduced HS initiation leading to an increased CS accumulation could explain the mild cartilage phenotypes observed in these mutants (Fig. 2, B, G, L, and Q).

The Balance between extl3 and csgalnact1/csgalnact2 Influences the HS/CS Ratio

Based on the molecular phenotypes of the extl3 larvae, we hypothesized that the balance between extl3 and csgalnact1/csgalnact2 expression impacts the HS/CS ratio (Fig. 1). We also hypothesized that blunting the activity of chsy1 to suppress CS polymerization would not impact HS biosynthesis, analogous to the finding in ext2 mutants, where HS biosynthesis, but not CS biosynthesis, was shown to be suppressed (Fig. 3A). To this end, morpholino injections of wild-type embryos to target chsy1 (27) or csgalnact1/csgalnact2 were performed. Morpholinos targeting chsy1 indeed resulted in a 50% decrease of CS production, whereas there was no effect on HS biosynthesis (Fig. 3B). In contrast, injection of a mixture of morpholinos to suppress the CS initiation enzymes Csgalnact1 (28, 29) and Csgalnact2 (29, 30) decreased CS accumulation and increased HS accumulation (Fig. 3C).

We next investigated whether a decrease in extl3 expression could affect the HS/CS substitution ratio on a specific proteoglycan core protein. HA-tagged AAS Syndecan-4 containing only a single GAG attachment site (26) was expressed in HEK cells treated with extl3-siRNA leading to reduction of the extl3 mRNA levels by ∼60% (data not shown). HA-tagged AAS Syndecan-4 was thereafter isolated by immunoprecipitation (supplemental Fig. S6). Interestingly, blunting of extl3 expression was shown to reduce the HS/CS ratio, so that AAS Syndecan-4 carried a larger proportion of CSase-sensitive material in siRNA-treated cells compared with control cells (Fig. 4). This illustrates that reduced Extl3 function can decrease the HS/CS ratio on a specific core protein at the level of a single GAG attachment site. Taken together, our data suggest that the balance between extl3 and csgalnact1/csgalnact2 expression affects the HS/CS ratio, possibly by a mechanism where there is competition or altered usage of available GAG linkage regions.

FIGURE 4.

FIGURE 4.

Suppression of extl3 results in increased relative levels of CS attached to AAS syndecan-4. HA-tagged AAS syndecan-4 was expressed in HEK293 cells transfected with siRNA control (A) or siRNA targeting extl3 (B). AAS syndecan-4 was further isolated by immunoprecipitation, and GAG attached to the core protein isolated and analyzed by gel filtration on a Superose 12 column. A, in the control condition, the intact GAGs (filled diamonds) eluted mainly as a single broad peak. CSase ABC digestion (gray diamonds) together with combined CSase ABC and nitrous acid treatment at pH 1.5 (open diamonds) showed that ∼30% of the high molecular weight GAG chains were of CS type. B, in the extl3-siRNA condition, the AAS syndecan-4 GAGs similarly eluted as a broad peak (filled circles). CSase ABC digestion (gray circles) together with combined CSase ABC and nitrous acid treatment at pH 1.5 (open circles) showed that ∼ 65% of the GAG chains were of CS type. The elution positions of 6-, 16-, and 26-mer dextran saccharide standards are shown. ctrl, control.

To test whether the increased accumulation of CS in extl3 mutants (Fig. 3A) contributed to the relatively mild cartilage phenotype seen here as compared with ext2 mutant larvae, morpholinos targeting chsy1 were injected in extl3 mutants. It was found that a decrease in CS synthesis in the extl3 morphants resulted in a stronger phenotype exhibiting compressed jaws with shorter and thicker cartilage elements (supplemental Fig. S5).

Differential Core Protein Expression, but Not Changes in CS Chain Length, May Contribute to Increased CS Content in extl3 Mutants

Cell culture experiments have previously shown that the length of GAG chains can be altered as a result of suppressed expression of GAG biosynthetic enzymes (31). To investigate whether the increased CS content in extl3 mutants could be explained by the formation of longer CS chains, we injected 5 dpf embryos with radioactive sulfate and isolated 35S-labeled GAGs at 18 h post-injection. A majority of the isolated total GAG chains were of CS type and susceptible to CSase cleavage (Fig. 5A and supplemental Table S2). The isolated GAG pools were also subjected to nitrous acid treatment that specifically degrades HS. It was concluded that the intact CS chain populations from both wild type and extl3 mutants had the same size distributions (Fig. 5B).

FIGURE 5.

FIGURE 5.

Increased CS content in extl3 mutants does not correlate to increased CS chain length. GAGs isolated from extl3 mutants and sibling controls were analyzed by gel filtration on a Superose 6 column. A, GAGs from the extl3 mutants (filled squares) and their siblings (open squares) exhibited identical elution profiles indicating no or very small differences in chain length. Treatment with CSase ABC cleaved most of the material both in extl3 mutants (filled diamonds) and siblings (open diamonds). B, nitrous acid treatment at pH 1.5 in addition degraded HS present in the total GAG pool isolated from extl3 mutants (filled circles) and siblings (open circles). Digestions with both CSase ABC and nitrous acid at pH 1.5 cleaved nearly all of the isolated material in both extl3 mutants (filled triangles) and siblings (open triangles). The elution positions of 4- and 26-mer dextran saccharide standards are indicated (see supplemental Table S2 for a quantification of the results). Ctrl, control.

Another possible mechanism for the increased CS content in extl3 mutants could possibly be altered expression of core proteins or glycosyltransferases involved in GAG polymerization. To this end, we quantified the expression of a number of genes directly involved in proteoglycan biosynthesis using a quantitative PCR approach. The expression levels of most investigated genes were similar in extl3 mutants and control embryos at 6 dpf (Fig. 6). Only the biglycan (bgna) mRNA level was significantly reduced in extl3 mutant embryos. However, a tendency for elevated aggrecan (acana) mRNA was seen in extl3 mutants (1.6-fold difference versus wild-type control; p = 0.25).

FIGURE 6.

FIGURE 6.

The expression levels of genes coding for proteoglycan core proteins and enzymes involved in polymerization of HS and CS are relatively unaffected in extl3 mutants. Real time quantitative PCR analysis was performed to evaluate the expression levels of selected genes extl3 mutant larvae compared with wild-type larvae isolated at 6 dpf (n = 3). The relative expression of genes coding for glycosyltransferases involved in HS and CS polymerization (A), membrane-tethered proteoglycan core proteins (B), or secreted proteoglycan core proteins (C) are shown. ctrl, control.

ext2 and extl3 Are Required for Normal HS Sulfation

Disaccharide analysis of HS produced by the mutant strains revealed that the proportion of sulfated disaccharides was increased in both ext2 and extl3 mutants. The prevalence of the disaccharide species devoid of sulfate groups (ΔHexA-GlcNAc) was decreased by 34% in ext2 mutants and 42% in extl3 mutants (Fig. 4), whereas the proportion of disaccharides modified by 6-O-sulfate groups was increased by 69 and 51%, respectively, in these mutants (supplemental Fig. S3A). The main consequence of the increased 6-O-sulfation was the increased occurrence of the ΔHexA2S-GlcNS6S disaccharide, commonly found in HS domains interacting with proteins, and a corresponding decrease in ΔHexA2S-GlcNS (Fig. 7). Interestingly, uxs1 and b3gat3 mutants displayed the opposite tendency with a decreased occurrence of ΔHexA2S-GlcNS6S and an increase of ΔHexA2S-GlcNS (Fig. 7).

FIGURE 7.

FIGURE 7.

extl3 and ext2 mutant larvae produce hypersulfated HS. The HS disaccharide profiles of all the mutant strains together with wild-type zebrafish larvae at 6 dpf are shown. Whereas extl3 and ext2 mutants produce an oversulfated HS, uxs1 and b3gat3 mutants essentially produce a wild-type HS with regard to overall degree of sulfation and disaccharide composition. The relative proportion of all disaccharides was determined for each sample. Disaccharide species are indicated as NAc (ΔHexA-GlcNAc), NS (ΔHexA-GlcNS), 6S (ΔHexA-GlcNAc6S), 2S (ΔHexA2S-GlcNAc), NS6S (ΔHexA-GlcNS6S), NS2S (ΔHexA2S-GlcNS), and NS6S2S (ΔHexA2S-GlcNS6S). The asterisks illustrate a significant difference in disaccharide content as compared with siblings (p < 0.05).

uxs1 and b3gat3 Mutants Are Incapable of CS 6-O-Sulfation

Despite the reduced and abnormal HS biosynthesis in ext2 and extl3 mutants, the level of CS sulfation in these mutants was found to be similar compared with control larvae (Fig. 8). In contrast, uxs1 and b3gat3 mutants produced very low amounts of CS with a striking reduction of ΔHexA-GalNAc6S disaccharide content accompanied by an increased content of ΔHexA-GalNAc4S disaccharides (Fig. 8).

FIGURE 8.

FIGURE 8.

uxs1 and b3gat3 mutant larvae produce undersulfated CS with reduced 6-O-sulfate content but with increased 4-O-sulfate content. The CS disaccharide profiles of the mutant strains together with wild-type zebrafish at 6 dpf are shown. extl3 and ext2 mutants produce a CS that is similar to that of wild type and uxs1 and b3gat3 mutants produce a CS with almost no 6-O-sulfate content but with up to a 2-fold increase of the 4-O-sulfate content. The relative proportion of each disaccharide was determined for each sample. Disaccharide species are indicated as 0S CS/Hya (ΔHexA-GalNAc/ΔHexA-GlcNAc), 4S (ΔHexA-GalNAc4S), 6S (ΔHexA-GalNAc6S), 2S (ΔHexA2S-GalNAc), 6S4S (ΔHexA-GlcNAc4S6S), 4S2S (ΔHexA2S-GalNAc4S), and 6S2S (ΔHexA2S-GalNAc6S). The asterisks illustrate a significant difference in disaccharide content as compared with siblings (p < 0.05).

ext2;uxs1 Double Mutants Have Stronger Cartilage Phenotypes than the Respective Single Mutants

Double mutants were created by introducing the ext2 mutant allele into the background of uxs1;Tg(fli:EGFP). The double mutants thus combine the ext2 genotype showing the strongest reduction of HS synthesis (18% of control) with the uxs1 genotype displaying the strongest reduction in CS synthesis (5% of control) (Fig. 3), to test the hypothesis that a strong suppression of both HS and CS biosynthesis simultaneously should lead to stronger phenotypes. To confirm that both HS and CS synthesis were suppressed in the ext2;uxs1 double mutants, we analyzed for GAG content of these larvae at 4 dpf; later stages were not amendable to analysis because of increased mortality. The HS content was shown to be reduced to 13% of control, and the CS content was reduced to 16% of control (Fig. 9A). The HS sulfation pattern in the double mutants was similar to that of ext2 and extl3 single mutants, with an increase in ΔHexA2S-GlcNS6S, but with the difference that there was a smaller reduction of ΔHexA2S-GlcNAc (Fig. 9B). The CS composition was shown to be similar to that of uxs1 and b3gat3 single mutants with a decrease in ΔHexA-GalNAc6S, but with the difference that there was less ΔHexA-GalNAc4S (Fig. 9C).

FIGURE 9.

FIGURE 9.

ext2;uxs1 double mutant larvae have severely reduced production of both HS and CS. A, HS and CS were quantitatively isolated from double mutants at 4 dpf (later stages were not amendable to analysis because of lethality) and analyzed using RPIP-HPLC. The amounts of HS and CS (pmol/larvae) in the mutant lines are shown as percentages of the levels found in sibling controls (set to 100%). B and C, the HS disaccharide profiles (B) and CS disaccharide profiles (C) of ext2;uxs1 double mutants compared with control zebrafish larvae at 4 dpf. The results show increase 6-O-sulfation of HS accompanied by decreased 6-O-sulfation of CS in the double mutants (p < 0.05).

The ext2;uxs1 double mutants were further shown to develop pharyngeal cartilage phenotypes that in a direct comparison were significantly stronger compared with the phenotypes found in the single ext2 and uxs1 mutants. Coherent groups of EGFP positive cells belonging to the pharyngeal arches were, however, identified in the double mutants (Fig. 10, D and H), indicating that low levels of HS and CS are tolerable for precartilage condensation. However, the pharyngeal cartilages were very small and severely misshaped at 4 dpf, and the anterior-posterior extension of the pharyngeal cartilage was also reduced compared with the control, as well as compared with the single mutants (Fig. 10).

FIGURE 10.

FIGURE 10.

Impaired HS biosynthesis leads to aberrant chondrocyte intercalation, and impaired CS biosynthesis inhibits ECM formation. Confocal imaging of live fli1:EGFP zebrafish larvae at 4 dpf. Shown are ventral views (A–D) and lateral views (E–H) of pharyngeal cartilage elements. A and E, control; B and F, ext2 mutants; C and G, uxs1 mutants; D and H, ext2;uxs1 double mutants. The lengths of the Meckel's cartilage (arrows in A–H) and the ceratohyal cartilage (stars in A–H) are significantly shorter in ext2;uxs1 double mutants compared with the ext2 and uxs1 mutants. The distance between the anterior end of Meckel's cartilage and the posterior end of the ceratohyal is indicated by brackets in A–D. Note that this distance is reduced in both ext2 and uxs1 mutants compared with control larvae and also strongly reduced in ext2;uxs1 double mutants. I–L show transmission electron microscopy images of the ceratohyal elements at 4 dpf. The rectangles in A–D serve to indicate the regions magnified in I–L. I, in control larvae, the chondrocytes are elongated and organized in rows surrounded by a thick layer of ECM. J–L, chondrocytes in ext2 mutants (J) are round and disorganized but still synthesize large amounts of ECM, whereas chondrocytes in uxs1 mutants (K) are tightly packed together and very little ECM can be detected (L). ext2;uxs1 double mutants produce lower amounts of ECM compared with uxs mutants, and most of the chondrocytes have neither elongated nor intercalated properly. Scale bars, 3 μm. M–P, lateral brightfield views of zebrafish larvae at 4 dpf. ext2;uxs1 double mutants (P) display a more severe jaw phenotype (arrow in P) compared with ext2 (N) and uxs1 (O) mutants. The double mutants also frequently develop a distinct pericardial edema (star in P) surrounding the heart, as well as exhibiting reduced eye size.

To study how different amounts of HS and CS affect cartilage development, we imaged the ultrastructure of the ceratohyal elements in larvae at 4 dpf using transmission electron microscopy. The chondrocytes in the control were shown to be fully intercalated and embedded in a thick layer of ECM (Fig. 10I). ext2 mutant chondrocytes, on the other hand, clearly failed to elongate and did not intercalate properly but were able to produce large amounts of ECM (Fig. 10J). Chondrocytes in uxs1 mutants also did not intercalate properly and in addition produced low levels of electron-dense ECM (Fig. 10K). Further, chondrocytes in ext2;uxs1 double mutants produced even less ECM than the uxs1 mutants, and, in addition, very few cells adopted an elongated shape (Fig. 10L). Taken together, these results suggest that the capacity to produce HS is required for proper chondrocyte intercalation, whereas reduced CS biosynthesis leads to impaired production of the ECM. The ceratohyal ECM of ext2 mutants was also shown to contain an organized collagen network, whereas only a few collagen fibers were observed in uxs1 mutants. Notably, no collagen fibers could be detected in ext2;uxs1 double mutants (supplemental Fig. S4).

Finally, analyses of the gross morphology showed that ext2;uxs1 double mutants displayed a more severe jaw phenotype compared with ext2 and uxs1 mutants, respectively. In addition, the double mutants also often showed pericardial edema and reduced eye size.

DISCUSSION

In this study we show that HS and CS biosynthesis in zebrafish larvae homozygous for mutations in either ext2, extl3, uxs1, or b3gat3 differs significantly from what could be hypothesized based on the results of previous studies and from the proposed positions of these enzymes in the GAG biosynthetic pathway (Fig. 1). Our study reveals that ext2 mutants contain less than half of the HS content of uxs1 and b3gat3 mutants. This provides an explanation for the fact that the uxs1 and b3gat3 pectoral fin phenotypes are weaker than the ext2 fin phenotype, because HS has been suggested to be critical for pectoral fin development (19). The present study also shows that extl3 mutants have milder cartilage phenotypes than ext2, uxs1, and b3gat3 mutants. This can be explained by the finding that extl3 mutants have increased CS biosynthesis (147% of control). The extl3 mutants therefore not only represent a HS loss of function model but also effectively represent a CS gain of function model. To our knowledge, this is the first time that a mutation in a GAG biosynthetic enzyme has resulted in quantitative up-regulation of CS biosynthesis in vivo. Finally, ext2;uxs1 double mutants, generated from the two single mutant strains with the most dramatic reduction in HS and CS, respectively, were shown to develop a significantly stronger pharyngeal cartilage phenotype compared with the individual single mutant strains (Fig. 10), confirming the key roles of both HS and CS in cartilage formation and demonstrating an additive effect of these mutations. It should be noted that the RPIP-HPLC analysis used here provides information on the structure and absolute levels of HS and CS, but on the other hand provides no information on the dynamic balance between synthesis and degradation, which might differ considerably between HSPGs and CSPGs (32).

The Relative Expression Levels of extl3 and csgalnact1/csgalnact2 Influence the HS/CS Ratio

Both HS and CS are synthesized onto a common PG linkage tetrasaccharide. Interestingly, the saccharides in the linkage region may be modified by phosphorylation and sulfation to possibly affect whether predominantly HS or CS will be synthesized onto the linkage region (3335). It has previously also been shown that domains present in PG core proteins influence the probability of modification by HS or CS (36). However, predicted purely from the biosynthetic scheme shown in Fig. 1, the activity or accessibility of enzymes adding either a GlcNAc (in the case of HS) or a GalNAc (in the case of CS) to the fourth sugar in the common linkage region will determine the type of GAG to be synthesized. Here, we show that the reduced initiation of HS biosynthesis in extl3 mutants leads to increased CS accumulation (Fig. 3A) and that a reduction of CS initiation by targeting Csgalnact1 and Csgalnact2 function results in increased HS accumulation (Fig. 3C). We also find that siRNA-mediated suppression of Extl3 in HEK cells decreases the HS/CS ratio on a single GAG attachment site in Syndecan-4, compatible with a mechanism where Extl3 and GalnacT1/T2 compete for linkage regions or alternatively suggesting that linkage regions that are not used for HS biosynthesis may be used for CS biosynthesis (Fig. 4).

The present study also examined whether the mRNA expression levels of several core proteins and enzymes involved in HS and CS biosynthesis were perturbed in extl3 mutant larvae. Whereas most of the investigated genes seems to be normally expressed in extl3 larvae, the biglycan mRNA level was reduced as compared with wild type (Fig. 6). Although not significant, a trend for increased levels of aggrecan mRNA in extl3 larvae was observed. This is interesting, because aggrecan may carry more than 100 CS chains per core protein unit. Because the lengths of CS chains in extl3 mutants are indistinguishable from wild type (Fig. 5), it could be that the increased amounts of CS produced in these fish are present on core proteins that normally carry mostly HS (e.g., syndecans) and/or that moderately elevated levels aggrecan also contribute to the increased CS levels. Based on the results presented here, we propose that the balance between extl3 and csgalnact1/csgalnact2 expression influences the HS/CS ratio, because these enzymes initiate HS and CS polymerization, respectively.

One additional explanation for the results obtained pertaining to the up-regulation of CS biosynthesis in extl3 mutants and the up-regulation of HS biosynthesis in csgalnact1/csgalnact2 morphants could be that cells respond to the low HS or CS production per se. Interestingly, however, no increased CS accumulation was seen in ext2 mutants despite a strong reduction in HS content (Fig. 3A), and no increased HS accumulation was seen in embryos injected with morpholinos targeting chsy1 expression despite a strong reduction in CS content (Fig. 3B). This argues against the possibility of a feedback mechanism in response to reduced GAG levels.

Signaling in HS and CS Depleted Cartilages

The molecular mechanisms that cause chondrocytes in cartilages to flatten and arrange themselves into columns are probably conserved and ancient in vertebrates (supplemental Fig. S1). Several recent studies suggest that the intercalation of chondrocytes occurs by convergent extension where noncanonical frizzled signaling regulates cell polarity (37, 38). Wnt signaling has an important role in controlling the transition of resting chondrocytes to proliferative and hypertrophic chondrocytes (39). Defective wnt5b function results in a chondrocyte stacking phenotype, similar to what has been observed in ext2 mutants (13). Recent studies also suggest that CS, in a fashion similar to HS, can influence Wnt signaling (40), and defects in chondrocyte stacking have been reported in mice with defective CS biosynthesis (41). It seems that defective Wnt signaling is likely to be part of the explanation for the observed defects in chondrocyte elongation and stacking in the GAG biosynthetic enzyme mutants investigated in the present study. However, it should be emphasized that the process of cartilage morphogenesis depends on a complex network of several types of paracrine signaling molecules, of which many if not all interact with HSPGs and in some cases also with CSPGs (42). In addition, there are many interactions between cells and the ECM where PGs play a central role (1, 2).

Different Effects on HS and CS Biosynthesis in uxs1 and b3gat3 Mutants

The reason(s) for why uxs1 and b3gat3 mutants still contain half of the normal HS content, whereas CS biosynthesis on the other hand is practically eliminated, needs to be discussed (Fig. 3A). Whereas the relative levels of the Extl3 and Csgalnact1/Csgalnact2 glycosyltransferases as shown here probably are important, there might still be other mechanisms that contribute to the molecular phenotypes in these mutants. One possibility is that chondrocytes in the uxs1 and b3gat3 mutants are unable to differentiate to a stage where normally large amounts of CS are efficiently produced and secreted, as indicated by the lack of maturation markers for chondrocytes in uxs1 mutants (11). Another possibility could be that the maternal contribution of uxs1 and b3gat3 mRNA in the mutants is insufficient for the sudden scaling up of CS biosynthesis by certain subpopulations of cells (e.g., chondrocytes) during chondrogenesis. Thus, the small residual amounts of CS detected at 6 dpf in uxs1 and b3gat3 mutants might have been mainly produced during the first days of zebrafish development. HS biosynthesis on the other hand occurs more evenly during embryo development (14), thereby potentially making more efficient use of the maternally contributed uxs1 and b3gat3 mRNA. Finally, it is also possible that alternative mechanisms yet to be identified exist to circumvent the lack of enzymatic activity in the respective mutants. For example, mechanisms for internalization and reglycanation of proteoglycans have been described (43) and would potentially provide a possibility for retaining some GAG biosynthesis in the mutants. If salvation pathways account for some of the GAGs detected in uxs1 and b3gat3 mutants or if other unknown mechanisms exist to compensate for the loss of GAG biosynthetic enzymatic activity in these mutants, such mechanisms might, however, be insufficient for the massive synthesis of CS to occur normally in chondrocytes.

Toward better Understanding of the Mechanisms behind MHE Onset

The results presented here could be of potential importance for understanding the biology behind the human disease multiple hereditary exostoses (MHE), also known as multiple osteochondromas. The mechanism for MHE onset is still debated (44). It is, however, generally accepted that mutations in either EXT1 or EXT2, leading to decreased HS synthesis in the bone growth plates, result in chondrocytes that are able to escape proliferation control (45). Interestingly, in contrast to mutations in the human EXT1 and EXT2 genes, mutations in the human EXTL3 gene have to our knowledge not been associated with MHE. Our study shows that zebrafish extl3 mutants, in addition to increased CS production, produce more HS than ext2 mutants. It is thus possible that the amounts of HS produced in extl3 mutants are enough to retain proliferation control over chondrocytes, explaining why this gene has so far not been implicated with MHE onset. Another possibility raised by this study is that the observed overproliferation of chondrocytes found in MHE patients could not be due to decreased HS production per se, but instead is an effect of the abnormally sulfated HS produced by chondrocytes having two mutated ext1 or ext2 alleles. Our analysis of HS produced by ext2 and extl3 mutants showed a clear increase in the occurrence of highly sulfated ΔHexA2S-GlcNS6S HS disaccharides in these mutants (Fig. 7). This disaccharide species is often part of HS motifs that avidly interact with growth factors (46). Previous studies have suggested that EXT proteins are interacting with the HS sulfotransferases and thus affecting HS modification (47). Notably, zebrafish uxs1 and b3gat3 displayed the opposite tendency with a decrease in ΔHexA2S-GlcNS6S, indicating that the increased proportion of this disaccharide is not solely an effect of reduced HS biosynthesis but depends on which specific gene function has been altered (Fig. 7).

If the key to MHE onset relates to increased sulfation of HS, it is on the other hand difficult to understand why extl3 mutations would not trigger the disease. Possibly, the increased CS production seen in this mutant could restore or normalize PG function, because CS has also been shown to have the capacity to impact growth factor signaling (40). At any rate, and in the light of our findings, it seems to be of great importance to analyze the GAG content of homozygous EXT1 and EXT2 mutant cells in tumor samples from patients with MHE to get a full view of the molecular phenotype. Finally, the data presented here underline the importance of GAG structural analysis to better understand the phenotypes arising from mutations in the different GAG biosynthetic enzymes, because at least to some extent there is an interplay between HS and CS biosynthesis.

Acknowledgments

We thank Professor Lena Kjellén for valuable discussions, Pancras C. W. Hogendoorn for sharing mutant lines, and Katrin Lundstedt-Enkel for statistical analysis.

*

The work was supported by funds from the Swedish Research Council (to J. K., P. A., and J. L.), the Swedish Cancer Society (to J. K., D. S., and A. E.), the Swedish Childhood Cancer Foundation (to J. K.), Swedish Foundation for Strategic Research Project A3 05:207g (to J. K.), the Foundation for Proteoglycan Research at Uppsala University (J. K., D. S., A. E.), the Knut and Alice Wallenberg Foundation (J. L., P. A.), and the Linnaeus Framework Grant “Genomics of Phenotypic Diversity in Natural Populations” (J. L., P. A.).

8

A. Amsterdam, personal communication.

7
The abbreviations used are:
ECM
extracellular matrix
HS
heparan sulfate
CS
chondroitin sulfate
PG
proteoglycan
GAG
glycosaminoglycan
HexA
hexuronic acid
hpf
hours post fertilization
RPIP
reverse phase ion pair
dpf
days post fertilization
MO
morpholino
MHE
multiple hereditary exostoses
CSase
Chondroitinase.

REFERENCES

  • 1. Kronenberg H. M. (2003) Developmental regulation of the growth plate. Nature 423, 332–336 [DOI] [PubMed] [Google Scholar]
  • 2. Goldring M. B., Tsuchimochi K., Ijiri K. (2006) The control of chondrogenesis. J. Cell Biochem. 97, 33–44 [DOI] [PubMed] [Google Scholar]
  • 3. Kimmel C. B., Miller C. T., Kruze G., Ullmann B., BreMiller R. A., Larison K. D., Snyder H. C. (1998) The shaping of pharyngeal cartilages during early development of the zebrafish. Dev. Biol. 203, 245–263 [DOI] [PubMed] [Google Scholar]
  • 4. Yao T., Ohtani K., Wada H. (2008) Whole-mount observation of pharyngeal and trabecular cartilage development in lampreys. Zoolog. Sci. 25, 976–981 [DOI] [PubMed] [Google Scholar]
  • 5. Janvier P., Arsenault M. (2007) The anatomy of Euphanerops longaevus Woodward, 1900, an anaspid-like jawless vertebrate from the Upper Devonian of Miguasha, Quebec, Canada. Geodiversitas 29, 143–216 [Google Scholar]
  • 6. Kreuger J., Spillmann D., Li J. P., Lindahl U. (2006) Interactions between heparan sulfate and proteins. The concept of specificity. J. Cell Biol. 174, 323–327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Lin X. (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131, 6009–6021 [DOI] [PubMed] [Google Scholar]
  • 8. Kreuger J., Perez L., Giraldez A. J., Cohen S. M. (2004) Opposing activities of Dally-like glypican at high and low levels of Wingless morphogen activity. Dev. Cell 7, 503–512 [DOI] [PubMed] [Google Scholar]
  • 9. LeClair E. E., Mui S. R., Huang A., Topczewska J. M., Topczewski J. (2009) Craniofacial skeletal defects of adult zebrafish Glypican 4 (knypek) mutants. Dev. Dyn. 238, 2550–2563 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Topczewski J., Sepich D. S., Myers D. C., Walker C., Amores A., Lele Z., Hammerschmidt M., Postlethwait J., Solnica-Krezel L. (2001) The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension. Dev. Cell 1, 251–264 [DOI] [PubMed] [Google Scholar]
  • 11. Eames B. F., Singer A., Smith G. A., Wood Z. A., Yan Y. L., He X., Polizzi S. J., Catchen J. M., Rodriguez-Mari A., Linbo T., Raible D. W., Postlethwait J. H. (2010) UDP xylose synthase 1 is required for morphogenesis and histogenesis of the craniofacial skeleton. Dev. Biol. 341, 400–415 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Wiweger M. I., Avramut C. M., de Andrea C. E., Prins F. A., Koster A. J., Ravelli R. B., Hogendoorn P. C. (2011) Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders. J. Pathol. 223, 531–542 [DOI] [PubMed] [Google Scholar]
  • 13. Clement A., Wiweger M., von der Hardt S., Rusch M. A., Selleck S. B., Chien C. B., Roehl H. H. (2008) Regulation of zebrafish skeletogenesis by ext2/dackel and papst1/pinscher. PLoS Genet. 4, e1000136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Lee J. S., von der Hardt S., Rusch M. A., Stringer S. E., Stickney H. L., Talbot W. S., Geisler R., Nüsslein-Volhard C., Selleck S. B., Chien C. B., Roehl H. (2004) Axon sorting in the optic tract requires HSPG synthesis by ext2 (dackel) and extl3 (boxer). Neuron 44, 947–960 [DOI] [PubMed] [Google Scholar]
  • 15. Schilling T. F., Piotrowski T., Grandel H., Brand M., Heisenberg C. P., Jiang Y. J., Beuchle D., Hammerschmidt M., Kane D. A., Mullins M. C., van Eeden F. J., Kelsh R. N., Furutani-Seiki M., Granato M., Haffter P., Odenthal J., Warga R. M., Trowe T., Nüsslein-Volhard C. (1996) Jaw and branchial arch mutants in zebrafish I. Branchial arches. Development 123, 329–344 [DOI] [PubMed] [Google Scholar]
  • 16. Walsh E. C., Stainier D. Y. (2001) UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science 293, 1670–1673 [DOI] [PubMed] [Google Scholar]
  • 17. Neuhauss S. C., Solnica-Krezel L., Schier A. F., Zwartkruis F., Stemple D. L., Malicki J., Abdelilah S., Stainier D. Y., Driever W. (1996) Mutations affecting craniofacial development in zebrafish. Development 123, 357–367 [DOI] [PubMed] [Google Scholar]
  • 18. Grandel H., Draper B. W., Schulte-Merker S. (2000) Dackel acts in the ectoderm of the zebrafish pectoral fin bud to maintain AER signaling. Development 127, 4169–4178 [DOI] [PubMed] [Google Scholar]
  • 19. Norton W. H., Ledin J., Grandel H., Neumann C. J. (2005) HSPG synthesis by zebrafish Ext2 and Extl3 is required for Fgf10 signalling during limb development. Development 132, 4963–4973 [DOI] [PubMed] [Google Scholar]
  • 20. Amsterdam A., Nissen R. M., Sun Z., Swindell E. C., Farrington S., Hopkins N. (2004) Identification of 315 genes essential for early zebrafish development. Proc. Natl. Acad. Sci. U.S.A. 101, 12792–12797 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Lawson N. D., Weinstein B. M. (2002) In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248, 307–318 [DOI] [PubMed] [Google Scholar]
  • 22. Westerfield M. (1995) The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 4th Ed., Univ. of Oregon Press, Eugene, OR [Google Scholar]
  • 23. van Eeden F. J., Granato M., Schach U., Brand M., Furutani-Seiki M., Haffter P., Hammerschmidt M., Heisenberg C. P., Jiang Y. J., Kane D. A., Kelsh R. N., Mullins M. C., Odenthal J., Warga R. M., Nüsslein-Volhard C. (1996) Genetic analysis of fin formation in the zebrafish, Danio rerio. Development 123, 255–262 [DOI] [PubMed] [Google Scholar]
  • 24. Ledin J., Staatz W., Li J. P., Götte M., Selleck S., Kjellén L., Spillmann D. (2004) Heparan sulfate structure in mice with genetically modified heparan sulfate production. J. Biol. Chem. 279, 42732–42741 [DOI] [PubMed] [Google Scholar]
  • 25. Zhang J., Lefebvre J. L., Zhao S., Granato M. (2004) Zebrafish unplugged reveals a role for muscle-specific kinase homologs in axonal pathway choice. Nat. Neurosci. 7, 1303–1309 [DOI] [PubMed] [Google Scholar]
  • 26. Gopal S., Bober A., Whiteford J. R., Multhaupt H. A., Yoneda A., Couchman J. R. (2010) Heparan sulfate chain valency controls syndecan-4 function in cell adhesion. J. Biol. Chem. 285, 14247–14258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Prabhakar V., Sasisekharan R. (2006) The biosynthesis and catabolism of galactosaminoglycans. Adv. Pharmacol. 53, 69–115 [DOI] [PubMed] [Google Scholar]
  • 28. Kitagawa H., Uyama T., Sugahara K. (2001) Molecular cloning and expression of a human chondroitin synthase. J. Biol. Chem. 276, 38721–38726 [DOI] [PubMed] [Google Scholar]
  • 29. Uyama T., Kitagawa H., Tanaka J., Tamura J., Ogawa T., Sugahara K. (2003) Molecular cloning and expression of a second chondroitin N-acetylgalactosaminyltransferase involved in the initiation and elongation of chondroitin/dermatan sulfate. J. Biol. Chem. 278, 3072–3078 [DOI] [PubMed] [Google Scholar]
  • 30. Guo S., Sato T., Shirane K., Furukawa K. (2001) Galactosylation of N-linked oligosaccharides by human β-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 11, 813–820 [DOI] [PubMed] [Google Scholar]
  • 31. Busse M., Feta A., Presto J., Wilén M., Grønning M., Kjellén L., Kusche-Gullberg M. (2007) Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J. Biol. Chem. 282, 32802–32810 [DOI] [PubMed] [Google Scholar]
  • 32. Esko J. D., Kimata K., Lindahl U. (2009) Proteoglycans and sulfated Glycosaminoglycans, in Essentials of Glycobiology (Varki A., Cummings R. D., Esko J. D., Freeze H. F., Stanely P., Bertozzi C. R., Hart W. H., Marilynn E. E., eds) 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY: [PubMed] [Google Scholar]
  • 33. Tone Y., Pedersen L. C., Yamamoto T., Izumikawa T., Kitagawa H., Nishihara J., Tamura J., Negishi M., Sugahara K. (2008) 2-O-phosphorylation of xylose and 6-O-sulfation of galactose in the protein linkage region of glycosaminoglycans influence the glucuronyltransferase-I activity involved in the linkage region synthesis. J. Biol. Chem. 283, 16801–16807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Gulberti S., Lattard V., Fondeur M., Jacquinet J. C., Mulliert G., Netter P., Magdalou J., Ouzzine M., Fournel-Gigleux S. (2005) Modifications of the glycosaminoglycan-linkage region of proteoglycans. Phosphorylation and sulfation determine the activity of the human β1,4-galactosyltransferase 7 and β1,3-glucuronosyltransferase I. Sci. World J. 5, 510–514 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Ueno M., Yamada S., Zako M., Bernfield M., Sugahara K. (2001) Structural characterization of heparan sulfate and chondroitin sulfate of syndecan-1 purified from normal murine mammary gland epithelial cells. Common phosphorylation of xylose and differential sulfation of galactose in the protein linkage region tetrasaccharide sequence. J. Biol. Chem. 276, 29134–29140 [DOI] [PubMed] [Google Scholar]
  • 36. Chen R. L., Lander A. D. (2001) Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J. Biol. Chem. 276, 7507–7517 [DOI] [PubMed] [Google Scholar]
  • 37. Li Y., Dudley A. T. (2009) Noncanonical frizzled signaling regulates cell polarity of growth plate chondrocytes. Development 136, 1083–1092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Ahrens M. J., Li Y., Jiang H., Dudley A. T. (2009) Convergent extension movements in growth plate chondrocytes require gpi-anchored cell surface proteins. Development 136, 3463–3474 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Yang Y., Topol L., Lee H., Wu J. (2003) Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130, 1003–1015 [DOI] [PubMed] [Google Scholar]
  • 40. Nadanaka S., Ishida M., Ikegami M., Kitagawa H. (2008) Chondroitin 4-O-sulfotransferase-1 modulates Wnt-3a signaling through control of E disaccharide expression of chondroitin sulfate. J. Biol. Chem. 283, 27333–27343 [DOI] [PubMed] [Google Scholar]
  • 41. Klüppel M., Wight T. N., Chan C., Hinek A., Wrana J. L. (2005) Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis. Development 132, 3989–4003 [DOI] [PubMed] [Google Scholar]
  • 42. Le Jan S., Hayashi M., Kasza Z., Eriksson I., Bishop J. R., Weibrecht I., Heldin J., Holmborn K., Jakobsson L., Söderberg O., Spillmann D., Esko J. D., Claesson-Welsh L., Kjellén L., Kreuger J. (2012) Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis. Arterioscler. Thromb. Vasc. Biol. 32, 1255–1263 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Edgren G., Havsmark B., Jönsson M., Fransson L. A. (1997) Glypican (heparan sulfate proteoglycan) is palmitoylated, deglycanated and reglycanated during recycling in skin fibroblasts. Glycobiology 7, 103–112 [DOI] [PubMed] [Google Scholar]
  • 44. Roehl H. H., Pacifici M. (2000) Shop talk. Sugars, bones, and a disease called multiple hereditary exostoses. Dev. Dyn. 239, 1901–1904 [DOI] [PubMed] [Google Scholar]
  • 45. Jennes I., Pedrini E., Zuntini M., Mordenti M., Balkassmi S., Asteggiano C. G., Casey B., Bakker B., Sangiorgi L., Wuyts W. (2009) Multiple osteochondromas. Mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum. Mutat. 30, 1620–1627 [DOI] [PubMed] [Google Scholar]
  • 46. Kreuger J., Jemth P., Sanders-Lindberg E., Eliahu L., Ron D., Basilico C., Salmivirta M., Lindahl U. (2005) Fibroblast growth factors share binding sites in heparan sulphate. Biochem. J. 389, 145–150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Presto J., Thuveson M., Carlsson P., Busse M., Wilén M., Eriksson I., Kusche-Gullberg M., Kjellén L. (2008) Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation. Proc. Natl. Acad. Sci. U.S.A. 105, 4751–4756 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES